International non- proprietary name: CetuximabBrand name: ErbituxTarget; Format: Erbitux EGFR; Chimeric IgG1Indication first approved or reviewed:  Colorectal cancerFirst EU approval year: 2004First US approved: 2004

Do you need a similar assignment done for you from scratch? We have qualified writers to help you. We assure you an A+ quality paper that is free from plagiarism. Order now for an Amazing Discount!
Use Discount Code "Newclient" for a 15% Discount!

NB: We do not resell papers. Upon ordering, we do an original paper exclusively for you.